Dr. Michael Silverstein, M.D

NPI: 1255587366
Total Payments
$8,699
2024 Payments
$79.90
Companies
27
Transactions
94
Medicare Patients
4,998
Medicare Billing
$1.4M

Payment Breakdown by Category

Other$7,267 (83.5%)
Food & Beverage$1,268 (14.6%)
Consulting$150.00 (1.7%)
Gifts$14.05 (0.2%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $7,267 4 83.5%
Food and Beverage $1,268 88 14.6%
Consulting Fee $150.00 1 1.7%
Gift $14.05 1 0.2%

Top Paying Companies

Company Total Records Latest Year
Supernus Pharmaceuticals, Inc. $7,361 10 $0 (2017)
Alkermes, Inc. $150.00 1 $0 (2017)
Allergan, Inc. $143.98 17 $0 (2021)
Biogen, Inc. $138.76 16 $0 (2021)
PFIZER INC. $113.68 7 $0 (2024)
Novartis Pharmaceuticals Corporation $99.69 5 $0 (2024)
EMD Serono, Inc. $93.60 6 $0 (2023)
Teva Pharmaceuticals USA, Inc. $81.54 4 $0 (2017)
Alexion Pharmaceuticals, Inc. $75.84 2 $0 (2021)
Celgene Corporation $62.48 4 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $79.90 4 PFIZER INC. ($37.66)
2023 $91.37 6 PFIZER INC. ($32.66)
2022 $172.15 10 EMD Serono, Inc. ($41.91)
2021 $184.61 9 Alexion Pharmaceuticals, Inc. ($53.50)
2018 $12.18 1 Lilly USA, LLC ($12.18)
2017 $8,158 64 Supernus Pharmaceuticals, Inc. ($7,361)

All Payment Transactions

94 individual payment records from CMS Open Payments — Page 3 of 4

Date Company Product Nature Form Amount Type
07/11/2017 Mitsubishi Tanabe Pharma America, Inc. Radicava (Drug) Food and Beverage Cash or cash equivalent $12.44 General
Category: Amyotrophic Lateral Sclerosis
07/07/2017 Allergan Inc. NAMZARIC (Drug), NAMENDA XR Food and Beverage In-kind items and services $10.33 General
Category: NEUROSCIENCE
06/30/2017 Supernus Pharmaceuticals, Inc. TROKENDI XR (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,667.00 General
Category: AED
06/30/2017 Supernus Pharmaceuticals, Inc. TROKENDI XR (Drug) Food and Beverage Cash or cash equivalent $22.50 General
Category: AED
06/30/2017 Supernus Pharmaceuticals, Inc. TROKENDI XR (Drug) Food and Beverage Cash or cash equivalent $12.50 General
Category: AED
06/30/2017 Supernus Pharmaceuticals, Inc. Food and Beverage Cash or cash equivalent $2.88 General
06/22/2017 Allergan Inc. NAMZARIC (Drug), NAMENDA XR Food and Beverage In-kind items and services $4.08 General
Category: NEUROSCIENCE
06/20/2017 Impax Laboratories, Inc. RYTARY (Drug) Food and Beverage In-kind items and services $18.25 General
Category: NEUROLOGY
06/16/2017 Biogen, Inc. TYSABRI (Biological), TECFIDERA Food and Beverage In-kind items and services $2.31 General
Category: NEUROLOGY
06/13/2017 Biogen, Inc. TYSABRI (Biological), TECFIDERA Food and Beverage In-kind items and services $21.97 General
Category: NEUROLOGY
06/13/2017 Biogen, Inc. TYSABRI (Biological), TECFIDERA Food and Beverage In-kind items and services $5.78 General
Category: NEUROLOGY
06/06/2017 ACADIA Pharmaceuticals Inc NUPLAZID (Drug) Food and Beverage In-kind items and services $16.16 General
Category: PDP
05/24/2017 Allergan Inc. NAMZARIC (Drug), NAMENDA XR Food and Beverage In-kind items and services $3.60 General
Category: NEUROSCIENCE
05/24/2017 Biogen, Inc. TYSABRI (Biological), TECFIDERA Food and Beverage In-kind items and services $2.17 General
Category: NEUROLOGY
05/23/2017 PFIZER INC. LYRICA (Drug) Food and Beverage In-kind items and services $11.27 General
Category: NEUROSCIENCE;PAIN
05/16/2017 Biogen, Inc. TECFIDERA (Drug), ZINBRYTA Food and Beverage In-kind items and services $12.54 General
Category: NEUROLOGY
05/16/2017 Biogen, Inc. TECFIDERA (Drug), ZINBRYTA Food and Beverage In-kind items and services $2.12 General
Category: NEUROLOGY
05/09/2017 Eisai Inc. Fycompa (Drug) Food and Beverage Cash or cash equivalent $36.01 General
Category: Neurology
05/05/2017 Alkermes, Inc. Consulting Fee Cash or cash equivalent $150.00 General
05/02/2017 Allergan Inc. NAMZARIC (Drug) Food and Beverage In-kind items and services $17.04 General
Category: NEUROSCIENCE
05/02/2017 Biogen, Inc. TYSABRI (Biological), TECFIDERA Food and Beverage In-kind items and services $2.46 General
Category: NEUROLOGY
05/02/2017 Allergan Inc. NAMZARIC (Drug) Food and Beverage In-kind items and services $2.04 General
Category: NEUROSCIENCE
05/01/2017 Supernus Pharmaceuticals, Inc. TROKENDI XR (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $250.00 General
Category: AED
04/28/2017 Supernus Pharmaceuticals, Inc. Food and Beverage Cash or cash equivalent $17.05 General
04/26/2017 Allergan Inc. NAMZARIC (Drug), NAMENDA XR Food and Beverage In-kind items and services $4.88 General
Category: NEUROSCIENCE

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 9 1,292 22,263 $1.5M $384,971
2022 9 1,465 20,410 $1.5M $431,610
2021 11 1,207 14,787 $1.3M $338,248
2020 12 1,034 10,774 $1.1M $244,116
Total Patients
4,998
Total Services
68,234
Medicare Billing
$1.4M
Procedure Codes
45

All Medicare Procedures & Services

45 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
J0585 Injection, onabotulinumtoxina, 1 unit Office 2023 31 20,645 $206,450 $102,333 49.6%
95813 Measurement of brain wave activity (eeg), 61-119 minutes Office 2023 210 210 $315,000 $82,575 26.2%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 281 468 $269,833 $46,749 17.3%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 205 276 $224,355 $42,232 18.8%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2023 200 200 $179,400 $35,864 20.0%
93886 Complete ultrasound of within the brain blood flow Office 2023 136 136 $81,600 $33,728 41.3%
93880 Ultrasound of both sides of head and neck blood flow Office 2023 136 136 $88,400 $18,842 21.3%
64615 Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face Office 2023 35 113 $73,450 $14,517 19.8%
95720 Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional Facility 2023 18 39 $78,000 $6,831 8.8%
93880 Ultrasound of both sides of head and neck blood flow Facility 2023 40 40 $22,000 $1,300 5.9%
95813 Measurement of brain wave activity (eeg), 61-119 minutes Office 2022 254 258 $387,000 $104,476 27.0%
J0585 Injection, onabotulinumtoxina, 1 unit Office 2022 27 18,600 $186,000 $90,762 48.8%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2022 282 282 $211,500 $53,648 25.4%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 281 483 $169,050 $50,548 29.9%
93886 Complete ultrasound of within the brain blood flow Office 2022 181 181 $108,600 $47,127 43.4%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 121 174 $69,600 $27,295 39.2%
93880 Ultrasound of both sides of head and neck blood flow Office 2022 182 182 $118,300 $26,666 22.5%
95720 Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional Facility 2022 44 87 $174,000 $15,654 9.0%
64615 Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face Office 2022 31 101 $65,650 $13,357 20.3%
93880 Ultrasound of both sides of head and neck blood flow Facility 2022 62 62 $34,200 $2,077 6.1%
95813 Measurement of brain wave activity (eeg) extended monitoring, 61-119 minutes Office 2021 187 187 $280,500 $75,951 27.1%
J0585 Injection, onabotulinumtoxina, 1 unit Office 2021 22 13,200 $132,000 $64,116 48.6%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 272 492 $172,200 $47,253 27.4%
99205 New patient outpatient visit, total time 60-74 minutes Office 2021 192 192 $144,000 $37,557 26.1%
93886 Ultrasound scanning of head and neck vessel blood flow (inside the brain) Office 2021 123 124 $74,400 $32,464 43.6%

About Dr. Michael Silverstein, M.D

Dr. Michael Silverstein, M.D is a Specialist healthcare provider based in Hackensack, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/09/2008. The National Provider Identifier (NPI) number assigned to this provider is 1255587366.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Silverstein, M.D has received a total of $8,699 in payments from pharmaceutical and medical device companies, with $79.90 received in 2024. These payments were reported across 94 transactions from 27 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($7,267).

As a Medicare-enrolled provider, Silverstein has provided services to 4,998 Medicare beneficiaries, totaling 68,234 services with total Medicare billing of $1.4M. Data is available for 4 years (2020–2023), covering 45 distinct procedure/service records.

Practice Information

  • Specialty Specialist
  • Location Hackensack, NJ
  • Active Since 08/09/2008
  • Last Updated 11/03/2011
  • Taxonomy Code 174400000X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1255587366

Products in Payments

  • TROKENDI XR (Drug) $7,341
  • KESIMPTA (Drug) $99.69
  • NAMZARIC (Drug) $92.30
  • NURTEC ODT (Drug) $85.88
  • TYSABRI (Biological) $85.08
  • COPAXONE (Drug) $81.54
  • ZEPOSIA (Drug) $62.48
  • Fycompa (Drug) $56.70
  • Soliris (Drug) $53.50
  • NUPLAZID (Drug) $43.96
  • Rebif (Biological) $37.34
  • RYTARY (Drug) $37.12
  • BOTOX (Biological) $35.38
  • TECFIDERA (Drug) $32.59
  • LYRICA (Drug) $26.51
  • Trudhesa (Drug) $23.07
  • SOLIRIS (Drug) $22.34
  • CALA TRIO (Device) $21.69
  • OCREVUS (Biological) $18.71
  • Briviact (Drug) $18.37

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Specialist Doctors in Hackensack